Skip to content

menu

Open Legal Blog Archive logo
HomeAboutBlogsFAQsSubmit

Latest Post

Five Career Defining Moments That Drive Me To Work With Life Science Companies

June 21, 2022

Feeling a little nostalgic about my career, which probably has a lot to do with my son starting his career journey this week.

I’ve been incredibly lucky to work with some of the best and most innovative life science companies. Here are five career defining moments:

  • I was part of a trial team in 2009
  • …

    More Posts

    You Don't Need a "Speak Up Culture", You Need a "Speak With Culture"!

    June 21, 2022

    Four Ways To Measure If You Have An Effective Compliance Investigation Process

    May 10, 2022

    Internal Audit + Compliance: Relationship status – it’s complicated!

    May 3, 2022

    What is a "Culture of Compliance" anyway?

    April 26, 2022

    First big DOJ Pharma settlement of 2022! Mallinckrodt will pay $260 million to settle two cases

    March 8, 2022

    Vyera settles FTC claims it prevented generic competition for $40 million

    December 8, 2021

    Interim Analysis: Former Immunomedic CFO arrested; WOW-jail time for OIG exclusion violation

    December 2, 2021

    Pharma Settlement: Kaleo pays $12.7 million, related to pharmacies submitting false prior auths

    November 10, 2021

    Medical Device False Claims Settlement – Arthrex will pay $16 million to resolve HCP kickback claim

    November 8, 2021
    Connect: Dan's Linkedin Profile
    Subscribe: Subscribe via RSS
    Blogs
    • The Curto Pharma Law Report
    Firm/Org
    • Curto Pharma Law and Compliance

    Dan Curto

    For more than 20 years Dan Curto has been focused on helping life sciences companies solve legal, compliance and regulatory challenges. Dan was a member of the international law firm of McDermott, Will & Emery from 1998 to 2012. As a partner at McDermott, his practice focused on guiding life sciences companies through government investigations, litigation, and compliance remediation. Since 2012, Dan has held various leadership positions at Sanofi, Biogen and BeiGene, including lead global commercial roles, heading a global investigation function that oversaw all internal and external compliance and government investigations and serving as head of global litigation and enterprise risk management. Dan opened Curto Pharma Law and Compliance in 2021 to provide counsel and compliance on demand support to Life Sciences companies.
    Connect: Dan's Linkedin Profile
    Subscribe: Subscribe via RSS
    Blogs
    • The Curto Pharma Law Report
    Firm/Org
    • Curto Pharma Law and Compliance
    Open Legal Blog Archive, Inc. logo
    Seattle, Washington
    Copyright © 2025, Open Legal Blog Archive, Inc. All Rights Reserved.
    Law blog design & platform by LexBlog LexBlog Logo